MarketsandMarkets is proud to announce the 6th Annual Real-World Evidence and Life Sciences Conference to be held on October 16th - 17th, 2023 at Hampton Inn by Hilton Boston Seaport District.
Real-world data and real-world evidence are poised to keep making strides in 2023.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.
Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.
Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance. This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.
RWE Principal at Forian, Forian Inc
Director, Commercial Data Science, Alnylam Pharmaceuticals
Associate Director, Data Scientist, Alnylam Pharmaceuticals
Director, Global Oncology Real World Data Strategy, AstraZeneca
Senior Medical Director, Clinical Development and Real-world Evidence, Lexeo Therapeutics
Senior Representative, Flatiron Health
Vice President, Commercial Lead, Real-World Data Marketplace, Prognos Health
Principal, Data & Analytics, Eversana
Data Sciences Lead, Takeda
Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen
Real-World Data Engagement Lead, Takeda
Senior Director, Life Science Solutions, Truveta
Chief Executive Officer, OM1 Inc
Sr. Director, Head of Pharmacoepidemiology in Specialty Care, Sanofi
Director, Vaccines RWE Scientist, Pfizer
Director, Research Consulting, Komodo Health
Senior Director of Real World Evidence, Sarepta Therapeutics
Senior Vice President - Real-World Evidence and HEOR Insights, Magnolia Market Access
Associate Director, Global HEOR Analytics Alexion, AstraZeneca RDU
Global HEOR & Access Evidence Lead, Executive Director, Neuroscience, Novartis
Hampton Inn by Hilton Boston Seaport District